Jul 24, 2024 | Press Release
OVERLAND PARK, Kan.—July 24 2024—Dr. Vince Clinical Research (DVCR), a full-service contract research organization (CRO) specializing in early-phase clinical trials, is pleased to announce “Accelerating Clinical & Drug Development Timelines with AI,”...
May 7, 2024 | Press Release
OVERLAND PARK, Kan.—May 08 2024—Dr. Vince Clinical Research (DVCR), a full-service contract research organization (CRO), today announced the appointment of Sheldon Preskorn, M.D., as its Senior Vice President of Neuroscience. Dr. Preskorn is a world-renowned...
Mar 13, 2024 | Press Release
OVERLAND PARK, Kan.—March 13 2024—Dr. Vince Clinical Research (DVCR), a contract research organization specializing in early phase trials, announced the first dosing in a Phase II multi-center trial of SPN-820 in adults with major depressive disorder (MDD). DVCR is...
Dec 12, 2023 | Press Release
OVERLAND PARK, Kan.–Dec 12 2023–Dr. Vince Clinical Research (DVCR), a full-service Phase I-II contract research organization (CRO) announced a new solution to conduct renal and hepatic impairment studies. The solution leverages trusted relationships and...
Sep 7, 2023 | Press Release
OVERLAND PARK, Kan.–September 06 2023–Dr. Vince Clinical Research (DVCR), a full-service clinical research organization (CRO), today announced the first dosing in Cingulate Therapeutics’ CTx-1301 Phase III dose-optimization onset and duration laboratory classroom...
Aug 29, 2023 | Press Release
Strategic collaboration amplifies accessibility to Clario’s Early Precision QT (EPQT) methodology, enabling biopharmaceutical firms to secure more accurate and cost-efficient cardiac safety data in early clinical development stages. Meticulous multi-stage evaluation...
Recent Comments